FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082876871> ?p ?o ?g. }

• W2082876871 endingPage "104" @default.
• W2082876871 startingPage "97" @default.
• W2082876871 abstract "Preclinical findings suggest that the inhibition of NMDA glutamatergic neurotransmission may have beneficial effects in the treatment of cocaine dependence. We hypothesized that memantine, a low potency, uncompetitive NMDA receptor antagonist, would be safe and effective in the treatment of cocaine dependence, particularly in preventing relapse to cocaine use in abstinent individuals. Cocaine dependent patients (N=112) were enrolled. The trial began with a 2-week placebo lead-in period during which patients received high-value voucher contingency management to induce abstinence. Participants were then randomized to receive either memantine 20mg bid (N=39) or placebo (N=42) for 12-weeks in combination with individual relapse-prevention therapy. The randomization was stratified by abstinence status during the lead-in period. The primary outcome was the weekly proportion of days of cocaine use. There were no significant differences in cocaine use outcome between the groups treated with memantine versus placebo. Thus, the efficacy of memantine 40 mg/d for the treatment of cocaine dependence was not supported. Urine-confirmed abstinence during the lead-in period was achieved by 44% of participants, and was a strong predictor of subsequent cocaine abstinence during the trial. This suggests that this clinical trial design, an intensive behavioral intervention during a lead-in period, resolves cocaine dependent patients into two subgroups, one that rapidly achieves sustained abstinence and may not need a medication, and another that displays persistent cocaine use and would most likely benefit from a medication to help induce abstinence. Targeting the latter subgroup may advance medication development efforts." @default.
• W2082876871 created "2016-06-24" @default.
• W2082876871 creator A5021687596 @default.
• W2082876871 creator A5023883969 @default.
• W2082876871 creator A5039751213 @default.
• W2082876871 creator A5048218438 @default.
• W2082876871 creator A5073707428 @default.
• W2082876871 creator A5083379140 @default.
• W2082876871 creator A5088256724 @default.
• W2082876871 date "2010-09-01" @default.
• W2082876871 modified "2023-10-16" @default.
• W2082876871 title "A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period" @default.
• W2082876871 cites W1950553701 @default.
• W2082876871 cites W1967443225 @default.
• W2082876871 cites W1969003769 @default.
• W2082876871 cites W1979545520 @default.
• W2082876871 cites W1980654847 @default.
• W2082876871 cites W1982554516 @default.
• W2082876871 cites W1982724855 @default.
• W2082876871 cites W1984667560 @default.
• W2082876871 cites W1984692505 @default.
• W2082876871 cites W1989266002 @default.
• W2082876871 cites W1993305722 @default.
• W2082876871 cites W1996109234 @default.
• W2082876871 cites W1999377754 @default.
• W2082876871 cites W2003590685 @default.
• W2082876871 cites W2005288574 @default.
• W2082876871 cites W2006691722 @default.
• W2082876871 cites W2007745798 @default.
• W2082876871 cites W2009075711 @default.
• W2082876871 cites W2012176342 @default.
• W2082876871 cites W2015499493 @default.
• W2082876871 cites W2016595675 @default.
• W2082876871 cites W2019591259 @default.
• W2082876871 cites W2023243943 @default.
• W2082876871 cites W2041864677 @default.
• W2082876871 cites W2052304909 @default.
• W2082876871 cites W2057263259 @default.
• W2082876871 cites W2058816259 @default.
• W2082876871 cites W2060358202 @default.
• W2082876871 cites W2063772291 @default.
• W2082876871 cites W2068026895 @default.
• W2082876871 cites W2069296272 @default.
• W2082876871 cites W2076154723 @default.
• W2082876871 cites W2084450389 @default.
• W2082876871 cites W2085155996 @default.
• W2082876871 cites W2102842111 @default.
• W2082876871 cites W2106719141 @default.
• W2082876871 cites W2114661800 @default.
• W2082876871 cites W2116524276 @default.
• W2082876871 cites W2122284725 @default.
• W2082876871 cites W2131107869 @default.
• W2082876871 cites W2138008971 @default.
• W2082876871 cites W2140991283 @default.
• W2082876871 cites W2143429166 @default.
• W2082876871 cites W2160630552 @default.
• W2082876871 cites W2161817834 @default.
• W2082876871 cites W2162992513 @default.
• W2082876871 cites W2167896264 @default.
• W2082876871 cites W2333574104 @default.
• W2082876871 cites W2411164228 @default.
• W2082876871 doi "https://doi.org/10.1016/j.drugalcdep.2010.04.006" @default.
• W2082876871 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2930076" @default.
• W2082876871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20537812" @default.
• W2082876871 hasPublicationYear "2010" @default.
• W2082876871 type Work @default.
• W2082876871 sameAs 2082876871 @default.
• W2082876871 citedByCount "45" @default.
• W2082876871 countsByYear W20828768712012 @default.
• W2082876871 countsByYear W20828768712013 @default.
• W2082876871 countsByYear W20828768712014 @default.
• W2082876871 countsByYear W20828768712015 @default.
• W2082876871 countsByYear W20828768712016 @default.
• W2082876871 countsByYear W20828768712018 @default.
• W2082876871 countsByYear W20828768712019 @default.
• W2082876871 countsByYear W20828768712020 @default.
• W2082876871 countsByYear W20828768712021 @default.
• W2082876871 countsByYear W20828768712022 @default.
• W2082876871 countsByYear W20828768712023 @default.
• W2082876871 crossrefType "journal-article" @default.
• W2082876871 hasAuthorship W2082876871A5021687596 @default.
• W2082876871 hasAuthorship W2082876871A5023883969 @default.
• W2082876871 hasAuthorship W2082876871A5039751213 @default.
• W2082876871 hasAuthorship W2082876871A5048218438 @default.
• W2082876871 hasAuthorship W2082876871A5073707428 @default.
• W2082876871 hasAuthorship W2082876871A5083379140 @default.
• W2082876871 hasAuthorship W2082876871A5088256724 @default.
• W2082876871 hasBestOaLocation W20828768712 @default.
• W2082876871 hasConcept C105867702 @default.
• W2082876871 hasConcept C118552586 @default.
• W2082876871 hasConcept C126322002 @default.
• W2082876871 hasConcept C142724271 @default.
• W2082876871 hasConcept C15744967 @default.
• W2082876871 hasConcept C168563851 @default.
• W2082876871 hasConcept C170493617 @default.
• W2082876871 hasConcept C204243189 @default.
• W2082876871 hasConcept C204787440 @default.
• W2082876871 hasConcept C27081682 @default.

• next